Harvard prof turns to private equity to counter Trump research cuts
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud. You can reach Allison on Signal at AllisonDeAngelis.01. A private equity firm has stepped in to finance a biological research lab at Harvard